Dilru Cheryl Amarasekera

Dilru Amarasekera practices at Wills Eye Hospital in Philadelphia, Pennsylvania, part of City Trusts.

Dilru Amarasekera's NPI, 1033606744, was assigned on April 18, 2018. Dilru Amarasekera graduated from Jefferson Medical College of Thomas Jefferson University in 2018. Dilru Amarasekera holds Pennsylvania license MD477445.

Dilru Amarasekera's primary practice is Wills Eye Hospital, at 840 Walnut Street, Philadelphia, PA 19107 in Philadelphia County. The practice phone is (215) 440-3150.

Dilru Amarasekera's primary practice is Wills Eye Hospital in Philadelphia, Pennsylvania, part of City Trusts. Dmand AI also links Dilru Amarasekera to 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dilru Amarasekera practices. Vendor and product names are available with a free account.

Ophthalmology is Dilru Amarasekera's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dilru Amarasekera is licensed in Pennsylvania.

CMS data shows 1,329 Medicare services from Dilru Amarasekera across 12 procedure codes in 2024, for 276 Medicare patients. Medicare paid $100,490 for them.

CMS counts 276 Medicare patients who saw Dilru Amarasekera in 2024. The largest group is 75 to 84, with 109 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 19% are also on Medicaid. Their average risk score is 1.34, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dilru Amarasekera's median patient age at 71, with 47% women.

In 2024, Dilru Amarasekera wrote 3,510 Medicare Part D claims for 632 patients. 70% of them were for generic drugs. CMS names the drug for 3,407 of them, across 24 drugs with 11 or more claims each, at $267,496 in total drug cost. In 2023, CMS named 839 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dilru Amarasekera for performance year 2024, reported as part of a group. Dilru Amarasekera accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 79 procedures of cataract surgery by Dilru Amarasekera, more than 71% of the clinicians it reports for that procedure.

Dmand AI links 9 papers to Dilru Amarasekera, published from 2016 to 2025. The most frequent topics are Ophthalmology and Glaucoma. Dilru Amarasekera's most frequent co-authors are Sally Liu Baxter, MD, Aiyin Chen, MD and Scott Jacob Fudemberg, MD.

CMS Open Payments shows 76 general payments to Dilru Amarasekera from 7 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 100% of the total. Alcon Laboratories Inc paid the most, $2,682.

Dilru Amarasekera graduated from Jefferson Medical College of Thomas Jefferson University in 2018.